Andrew Saunders
Technik-/Wissenschafts-/F&E-Leiter bei CellCentric Ltd.
Profil
Andrew Saunders is currently the Chief Medical Officer at CellCentric Ltd.
He previously worked as the Managing Director at Linden Oncology Ltd.
and as the Chief Medical Officer at Bioenvision, Inc. and Lytix Biopharma AS.
He also served as the Co-Chief Medical Officer at Redx Pharma Plc from 2018 to 2021.
Dr. Saunders earned a doctorate degree from Trinity College Dublin in 1989.
Aktive Positionen von Andrew Saunders
Unternehmen | Position | Beginn |
---|---|---|
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Andrew Saunders
Unternehmen | Position | Ende |
---|---|---|
REDX PHARMA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2007 |
Linden Oncology Ltd. | Vorstandsvorsitzender | - |
LYTIX BIOPHARMA | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Andrew Saunders
Trinity College Dublin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
LYTIX BIOPHARMA | Health Technology |
REDX PHARMA PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Linden Oncology Ltd. |